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ABSTRACT Bacterial conjugation is a mechanism of horizontal DNA transfer. The re-
laxase TrwC of the conjugative plasmid R388 cleaves one strand of the transferred
DNA at the oriT gene, covalently attaches to it, and leads the single-stranded DNA
(ssDNA) into the recipient cell. In addition, TrwC catalyzes site-speciﬁc integration of
the transferred DNA into its target sequence present in the genome of the recipient
bacterium. Here, we report the analysis of the efﬁciency and speciﬁcity of the inte-
grase activity of TrwC in human cells, using the type IV secretion system of the hu-
man pathogen Bartonella henselae to introduce relaxase-DNA complexes. Compared
to Mob relaxase from plasmid pBGR1, we found that TrwC mediated a 10-fold in-
crease in the rate of plasmid DNA transfer to human cells and a 100-fold increase in
the rate of chromosomal integration of the transferred DNA. We used linear
ampliﬁcation-mediated PCR and plasmid rescue to characterize the integration pat-
tern in the human genome. DNA sequence analysis revealed mostly reconstituted
oriT sequences, indicating that TrwC is active and recircularizes transferred DNA in
human cells. One TrwC-mediated site-speciﬁc integration event was detected, prov-
ing that TrwC is capable of mediating site-speciﬁc integration in the human ge-
nome, albeit with very low efﬁciency compared to the rate of random integration.
Our results suggest that TrwC may stabilize the plasmid DNA molecules in the nu-
cleus of the human cell, probably by recircularization of the transferred DNA strand.
This stabilization would increase the opportunities for integration of the DNA by the
host machinery.
IMPORTANCE Different biotechnological applications, including gene therapy strate-
gies, require permanent modiﬁcation of target cells. Long-term expression is achieved
either by extrachromosomal persistence or by integration of the introduced DNA.
Here, we studied the utility of conjugative relaxase TrwC, a bacterial protein with
site-speciﬁc integrase activity in bacteria, as an integrase in human cells. Although it
is not efﬁcient as a site-speciﬁc integrase, we found that TrwC is active in human
cells and promotes random integration of the transferred DNA in the human ge-
nome, probably acting as a DNA chaperone until it is integrated by host mecha-
nisms. TrwC-DNA complexes can be delivered to human cells through a type IV se-
cretion system involved in pathogenesis. Thus, TrwC could be used in vivo to
transfer the DNA of interest into the appropriate cell and promote its integration. If
used in combination with a site-speciﬁc nuclease, it could lead to site-speciﬁc inte-
gration of the incoming DNA by homologous recombination.
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Bacterial conjugation is an efﬁcient mechanism of horizontal DNA transfer whichconfers bacteria an elevated level of genomic plasticity (1). DNA is transferred by
conjugation from a donor to a recipient bacterium through a protein complex known
as conjugative apparatus (2). In Gram-negative bacteria, the conjugative machinery is
composed of three functional modules (3): (i) the relaxosome, a complex formed by the
DNA to be transferred (in particular the site known as origin of transfer [oriT]) and the
proteins responsible for DNA processing, which include a relaxase and one or more
accessory proteins; (ii) the type IV secretion system (T4SS), a multiprotein complex
organized in a transmembranal conduit that spans both inner and outer membranes;
and (iii) the coupling protein (T4CP), a DNA-dependent ATPase which brings together
the two previous components and is believed to play a crucial role in substrate
selection. The translocated substrate is the relaxase covalently linked to the transferred
DNA strand.
R388 is a conjugative plasmid with a broad host range that belongs to the IncW
incompatibility group (4). The 15-kb transfer region can be separated into an Mpf
(mating pair formation) region, which encodes the T4SS apparatus, and a Dtr (DNA
transfer and replication) region encoding the T4CP and the relaxosome (5). The Dtr
region is composed of an oriT of 330 bp in length, the relaxase TrwC, and two accessory
proteins, the plasmid-encoded TrwA and the host-encoded integration host factor (IHF)
(6). During conjugation, TrwC binds to the oriT gene, cleaves the DNA strand to be
transferred at the nic site, and makes a covalent bond with its 5= end (7). Then, the
relaxase-DNA complex is recruited by the T4CP to the T4SS and transported to the
recipient cell, where TrwC catalyzes the recircularization of the transferred DNA strand
(8, 9).
Apart from its role in conjugation, TrwC is able to catalyze site-speciﬁc recombina-
tion between two oriT copies repeated in tandem (10). The reaction takes place in the
absence of conjugation and thus in the absence of single-stranded intermediates, and
it is favored by the accessory protein TrwA. In contrast, IHF was found to exert a
negative regulatory role in TrwC-mediated recombination (11). It was proposed that
recombination takes place thanks to the single-stranded endonuclease activity of TrwC
coupled to the replication machinery of the host cell (10).
Once transferred to the recipient cell during conjugation, TrwC can also catalyze
site-speciﬁc integration of the transferred DNA strand into an oriT-containing plasmid
in the recipient cells (8). In this case, both TrwA and IHF act as enhancers of the reaction.
Integration also occurs when the acceptor oriT was located in the chromosomal DNA of
the recipient cell (12). A minimal oriT core sequence of 17 bp is enough for TrwC to
achieve integration. Two human sequences with a single mismatch from that minimal
oriT were tested as acceptors for TrwC-mediated integration and found to be func-
tional, with an efﬁciency only 2 to 3 times lower than that obtained with the wild-type
minimal oriT; this indicates that TrwC can act on DNA sequences present in the human
genome (12).
In addition to the T4SS involved in conjugative DNA transfer, there is another family
of T4SS implicated in the secretion of effector proteins during the infection process of
several mammalian and plant pathogens (13). Substrate recruitment by the T4SS relies
on secretion signals present in the protein substrate, and there are several examples of
heterologous protein translocation by the T4SS upon the addition of secretion signals.
In particular, conjugative relaxases can be translocated into eukaryotic cells through the
T4SS of bacterial pathogens, either unmodiﬁed due to some similarity in their C termini
with the secretion signal of the speciﬁc T4SS (as reported for translocation of MobA
encoded by plasmid RSF1010 by the VirB T4SS of Agrobacterium tumefaciens [14]), or
upon addition of the corresponding secretion signal, as done with TraA encoded by
plasmid pATC58 and the VirB/D4 T4SS of Bartonella henselae (15). Moreover, two
different reports have demonstrated that relaxase-DNA complexes from two conjuga-
tive systems can be translocated into human cells through the VirB/D4 T4SS of B.
henselae. Those studies reported relaxase-mediated transfer of bacterial plasmids con-
taining the oriT and conjugative genes from Bartonella cryptic plasmid pBGR1 (16) or
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from conjugative plasmid R388 (17). For both relaxases, the addition of a BID domain,
the translocation signal for the Bartonella VirB/D4 T4SS (15), increases DNA transfer (16,
18). These reports suggest that transkingdom DNA transfer may naturally occur during
bacterial infection of human cells.
T4SS-mediated DNA transfer to human cells may have biotechnological applications
as a tool for in vivo DNA delivery into speciﬁc human cells (19). A main concern in
genetic modiﬁcation protocols is the fate of the introduced foreign DNA in the cells.
Schröder and coworkers found that the relaxase-driven DNA integrated into the human
genome at low frequency, and they characterized several integration sites demonstrat-
ing that the pBGR1 Mob relaxase can protect the 5= end of the mobilizable plasmid, but
no preference for speciﬁc integration sites could be identiﬁed, suggesting random
integration of the incoming DNA (16).
In contrast to Mob, TrwC has site-speciﬁc integrase activity in bacteria, conferring
added potential as a tool for genomic engineering (20). In this work, we analyze TrwC
integrase activity into human genomic DNA after the mobilization of TrwC-DNA
complexes from B. henselae. We show evidence that TrwC is active in the human cell,
although the efﬁciency of site-speciﬁc integration is negligible compared to that of
random integration. Interestingly, we ﬁnd that TrwC promotes a 100-fold increase in
the efﬁciency of integration of the incoming DNA, suggesting it may be protecting DNA
from degradation; this feature could be combined with the action of a site-speciﬁc
nuclease for genomic engineering purposes.
RESULTS
Construction of mobilizable plasmids and target cell lines. TrwC-DNA complexes
can be introduced in human cell lines through the T4SS of B. henselae. In order to
analyze the integration pattern of the transferred DNA upon Bartonella infection of
human cells, new mobilizable plasmids and cell lines were constructed. The mobilizable
plasmids previously used to test DNA transfer from B. henselae to human cells (17)
contained elements of the R388 Dtr region (oriT trwABC), but not the genes of the T4SS,
and a eukaryotic gfp expression cassette. We added a neomycin phosphotransferase
eukaryotic expression cassette in order to be able to select for stable chromosomal
integration events. Plasmids were constructed coding for either TrwC or TrwC::BID
(TrwC with the secretion signal for Bartonella VirB/D4 T4SS fused to its C terminus), with
a negative control lacking trwC. Plasmid pRS130 (16) encoding Mob::BID relaxase and
its cognate oriT was always tested in parallel.
The cell lines used for Bartonella infections were EA.hy926 and HeLa. The EA.hy926
cell line is derived from fusion of A549 lung carcinoma cells with human vascular
endothelial cells, with endothelial cells representing the natural target for Bartonella
and that are efﬁciently infected by this bacterium (21). HeLa cells represent a cervix-
derived epithelial cell line that can be easily manipulated by cell biological and genetic
methods, and infection by B. henselae was reported to occur with 50% efﬁciency (22).
We previously showed DNA transfer to EA.hy cells, but HeLa cells were not tested.
EA.hy926 and HeLa cells were tested in parallel in infections with B. henselae carrying
either pHP161 (oriT trwABC) or pHP181 (oriT trwAB). DNA transfer efﬁciency was lower
when using HeLa than when using EA.hy926 cells, but DNA transfer can be detected
robustly in both cell lines (Fig. 1).
In order to compare the frequencies of TrwC-mediated integration into natural
sequences of the human genome with integration when the TrwC target is present in
the recipient cell genome, a cell line containing a full-length wild-type oriT gene was
constructed. We transfected both EA.hy926 and HeLa cells with plasmids pMTX708 and
pMTX709 (Table 1) carrying a hygromycin resistance gene and the R388 oriT in both
orientations. Both plasmids were used to avoid any bias due to eukaryotic promoters
present in the vector, since transcription through oriT has been shown to affect
TrwC-mediated recombination (11), and so it might affect integration. Around 100
hygromycin-resistant colonies were obtained in transfections of HeLa cells, while no
transfectants appeared for EA.hy926 in spite of several attempts with up to 5 g of
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plasmid DNA. Consistent with this ﬁnding, the EA.hy926 cell line has been previously
reported to be difﬁcult to transfect (22, 23).
The hygromycin-resistant HeLa colonies obtained were pooled to establish a poly-
clonal HeLa::oriT cell line, in which the oriT gene is expected to be located in different
chromosomal locations and in the two possible orientations with respect to the vector
promoter. In this way, we avoid selecting a single clone in which the oriT copy may lie
in a chromosomal region that could affect integration of the mobilizable plasmid. The
presence of the oriT gene was tested by PCR on genomic DNA samples from HeLa and
HeLa::oriT cells using primers oriT1 and oriT330 (Table 2). Only one band corresponding
to oriT was present in the sample obtained from HeLa::oriT cells, while no ampliﬁcation
was detected in the sample obtained from unmodiﬁed cells (see Fig. S2 in the supplemen-
tal material).
Transient and permanent expression of transferred DNA in human cells. In
order to measure the transfer and integration rates of DNA molecules led by different
relaxases into human cells, gfp and neo resistance gene expression levels were mea-
sured, respectively, as outlined in Fig. 2a. EA.hy926, HeLa, and HeLa::oriT cell lines were
infected with B. henselae carrying pCOR31 (trwC), pCOR33 (trwC::BID), pCOR35 (ΔtrwC),
or pRS130 (mob:BID) mobilizable plasmids. The results are shown in Fig. 2 and Table S2.
Three days postinfection, gfp expression was measured by ﬂow cytometry (Fig. 2b).
DNA transfer occurred in the three different cell lines when a relaxase (TrwC, TrwC::BID,
TABLE 1 Plasmids used in this work
Plasmid Description Reference or source
pCOR31 pBBR6::oriT trwABC gfp neo This work
pCOR33 pBBR6::oriT trwABC:BID gfp neo This work
pCOR35 pBBR6::oriT trwAB gfp neo This work
pCOR52 Rescued integrated plasmid This work
pHP159 pBBR6::oriT trwABC gfpa 17
pHP161 pBBR6::oriT trwABC gfpa 17
pHP181 pBBR6::oriT trwAB gfp 17
pKK223-3 Expression vector Pharmacia
pLA24 pBBR6::oriT trwABC:BID gfp 17
pMTX708 pTRE2hyg::Ptac-oriTb This work
pMTX709 pTRE2hyg::Ptac-oriTb This work
pOD1 pKK223-3::oriT This work
pRS56 Cre-lox neo 15
pRS130 pBGR::mob:BID gfp neo 16
pSU1186 pUC8::oriT 38
pTRE2hyg Mammalian shuttle vector Clontech
apHP159 and pHP161 differ only in the orientation of the gfp cassette, which is in the same orientation as
the Plac promoter in pHP161 and in the opposite in pHP159.
bpMTX708 and pMTX709 differ only in the orientation of the Ptac-oriT cassette. In pMTX708, oriT is closer to
the hygromycin resistance gene.
FIG 1 DNA transfer to EA.hy926 and HeLa cell lines. The graph shows the percentage of GFP-positive
cells detected after 3 days of infection. The cell lines indicated in the x axis were infected with B. henselae
carrying the mobilizable plasmids pHP181 (containing R388 oriT trwAB) or pHP161 (coding for R388 oriT
trwABC); this is indicated as AB or ABC, respectively. Data are the means of the results from at least 5
independent experiments. Error bars indicate standard deviations. **, P  0.01.
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or Mob::BID) was coded for in the plasmid, while no DNA transfer was detected when
there was no relaxase. The transfer efﬁciency is higher when using EA.hy926 than when
using HeLa as the host cell, as previously shown (Fig. 1). No signiﬁcant differences were
found in DNA transfer between the HeLa and HeLa::oriT cell lines, as expected. In all cell
lines, the DNA transfer rate was signiﬁcantly lower when using Mob::BID relaxase than
with TrwC or TrwC::BID.
Integration events of the transferred plasmids into the human genome were se-
lected by antibiotic treatment with G418. The drug was added at 72 hours postinfection
TABLE 2 Oligonucleotides used in this work
Oligonucleotide Sequence (5= to 3=)
Construction of pCOR31, pCOR33, and pCOR35
mCla_SnaBI_CMV_NeoF CCAAATCGATCTACGTATTAGTCATCGCTATT
Cla_EcoRV_NeoR CCAAATCGATGATATCCGGATATAGTTCC
Construction of pMTX708/pMTX709
NotI_Ptac CCAGCGGCCGCTTATCGACTGCACGG
NotI_oriT1 CCAGCGGCCGCTCATTTTCTGCATCATTGT
Detection of oriT-speciﬁc integration events
Int_pCOR TCAGGGCGTCCGTTTC
Int_pCOR_2 CTGCATCACATTTGCATC
NotI_Ptac CCAGCGGCCGCTTATCGACTGCACGG
NotI_Ptac_2 CACTGCATAATTCGTGTC
NotI_oriT1 CCAGCGGCCGCTCATTTTCTGCATCATTGT
PCR mapping of inserts in recovered
integrated plasmids
pCOR33_121F TGGACAACCCTGCTGGAC
pCOR33_644R TTTCGCCCTATATCTAGTTC
pCOR33_1641F CTCGACCTGAATGGAAGCC
pCOR33_2158R AGCTGGCGTAATAGCGAAG
pCOR33_3157F CGCAACCCCTTGTAAATGC
pCOR33_3664R TCTGAACGGCGGTAATCC
pCOR33_10431F CCTGGCTGACCGCCCAA
pCOR33_10940R GCTTCTAGAGATCTGACGG
pCOR33_11927F TCAGGTTCAGGGGGAGGT
pCOR33_12445R AATACGCAAACCGCCTCTC
Detection of oriT in HeLa::oriT
oriT1 CTCATTTTCTGCATCATCA
oriT330 CCTCTCCCGTAGTGTTA
Analysis of G418-resistant cell pools
670_TrwC TGTGTGCTAGGTCGAA
BamHI_TrwA_R AACAGGATCCTCAATCCTCCTTCCCCTCCC
Hind3_TrwA_F AACAAAGCTTATGGCACTAGGCGACCCC
Hind3_TrwC_F AACAAAGCTTATGCTCAGTCACATGGTATT
LAM-PCR and high-throughput sequencing
LC1 GACCCGGGAGATCTGAATTCAGTGGCACAGCAGTTAGG(N)12CTA(RO)a
LC2 (RO)TAG(N)12CCTAACTGCTGTGCCACTGAATTCAGATCa
LCI GACCCGGGAGATCTGAATTC
Mis-LC (PE-PCR 2.0)AGTGGCACAGCAGTTAGGb
Mis-TrwC (PE-PCR 1.0)(N)10CGTCCTTAAAAGCCGGGTTGc
oriTI CGATAACCCAATGCGCATAG
oriTII TCTTTAGGGTCACGCTGGC
PE-PCR 1.0 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
PE-PCR 2.0 CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCT
Sequencing of human genomic DNA
Chr15_88728 ATATGAATGTTTGCATTCCTT
IS2_Hu11 AAGAAAGTCAACCTTCATCTT
Xba_IS2_Hu11 CAACTCTAGAGGAAAAGTCAGAAAGACACCAAC
a(N)12, barcode sequence of linker cassette. (RO), restriction enzyme overhang.
b(PE-PCR 2.0), adaptor sequences for high-throughput sequencing.
c(PE-PCR 1.0), adaptor sequences for high-throughput sequencing; (N)10, barcode sequence introduced in second exponential PCR.
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(hpi), and selection was maintained for 4 to 5 weeks. The resistant colonies obtained for
each experimental condition were counted and then pooled. High-molecular-weight
genomic DNA preparations were analyzed by PCR for the presence of trwA and trwC to
conﬁrm the presence of the integrated plasmid (Fig. S3). The resistant cell pools were
also analyzed by ﬂow cytometry to detect green ﬂuorescent protein (GFP) expression
as additional evidence of integration of the mobilizable plasmids (Fig. S4).
Figure 2c shows the number of resistant colonies obtained after the antibiotic
treatment normalized to the number of cells at the beginning of the experiment. It was
lower when using EA.hy926 than when using HeLa cells, despite the fact that DNA
transfer was up to 10-fold higher with EA.hy926. For all cell lines, no resistant colonies
were found when using plasmid with ΔtrwC, in concordance with the ﬂow cytometry
results, which showed no DNA transfer in the absence of relaxase. When plasmids
coded for a relaxase, resistant colonies appeared but at drastically different rates.
Thousands of resistant colonies were obtained in each experiment after the mobiliza-
tion of trwC- and trwC::BID-carrying plasmids, while only up to 100 resistant colonies
were found in infections with B. henselae carrying the plasmid coding for Mob::BID (see
Table S2).
Figure 2d shows the ratio between neomycin-resistant (Neor) colonies and GFP
cells, which gives the integration rate, i.e., the proportion of cells receiving the DNA in
the nucleus which integrate this DNA into the chromosome. For each cell line, no
signiﬁcant differences were found in the integration rates of TrwC or TrwC::BID plas-
mids, as expected. No signiﬁcant differences were found either in the integration rate
FIG 2 Transient and permanent expression of the transferred DNA. (a) Overview of the experimental design to detect transient expression
or stable integration of the transferred DNA. After infection of human cell lines with B. henselae, the DNA transferred through the T4SS
will get to the nucleus where genes will be expressed. At 3 days postinfection, transient expression of gfp can be detected by ﬂow
cytometry. Antibiotic treatment was applied for long-term selection of neomycin-resistant colonies, to detect stable integration events.
(b to d) Graphic representation of the percentage of GFP-positive cells obtained 3 days postinfection (b) and the number of G418-resistant
colonies normalized for the number of cells at the beginning of the selection (c), as well as the Neor/GFP ratio (d). The different bars
represented for each cell line correspond to the different relaxases under study, following the color code indicated in the squares at the
top right. Data represent the means of the results from at least 3 independent experiments. Error bars indicate standard deviations. *, P 
0.05.
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of each plasmid in HeLa and HeLa::oriT cells. The integration rate was higher than 1 in
20 when the transferred DNA was led by TrwC or TrwC::BID, while it was around 1 in
250 in the case of Mob::BID-driven DNA (Table S2).
With the purpose of having a parallel control of random integration, HeLa and
HeLa::oriT cells were transfected with plasmid pCOR35 (ΔtrwC). Transient versus stable
expression was determined as outlined before. After transfection of plasmid DNA, we
obtained an integration rate of around 1 in 800 when transfecting supercoiled DNA and
of close to 1 in 300 when transfecting linearized DNA (Table S2), which is in the range
of our data obtained for Mob::BID. Antibiotic-resistant colonies were pooled and
analyzed in parallel with those obtained after relaxase-mediated mobilization of plas-
mid DNA to compare the two plasmid integration patterns.
Characterization of genomic integration sites. Relaxases transfer the DNA strand
covalently linked to a site known as the nic site. In the case of Mob-led DNA, it has been
suggested that the relaxase protects the 5= end of this DNA (16). In addition, we know
that TrwC acts as a site-speciﬁc integrase of the transferred DNA into the genome of
recipient bacteria (12), and we observed an enhanced integration rate of TrwC-led DNA.
Taking together these evidences, we decided to search for integration events occurring
at the nic site of the R388 oriT. For this purpose, we used linear ampliﬁcation-mediated
PCR (LAM-PCR) (24, 25) using a primer annealing close to the nic site, as explained in
Fig. S1. This strategy would not detect insertions into the full-length oriT copy of
HeLa::oriT, as integration would result in a reconstituted oriT, but it would allow the
identiﬁcation of integration events in other chromosomal locations and a comparison
with the integration pattern obtained when the oriT is not present in the genome to be
modiﬁed.
LAM-PCR was performed as explained in Materials and Methods and the supple-
mental Materials and Methods. Genomic DNA was extracted from pools of several
thousands of resistant colonies obtained after mobilization of trwC- or trwC::BID-coding
plasmids, and this DNA was used as the template for the PCRs. Genomic DNA was also
extracted from resistant colonies obtained by transfection of plasmids pCOR31 (trwC)
and pCOR33 (trwC::BID), which are expected to have a random integration pattern. After
LAM-PCR ampliﬁcation of the integration junctions, two different restriction enzymes
were used to avoid any bias due to restriction fragment size. PCR products were
checked by electrophoresis in agarose gels (Fig. 3).
Figure 3a to c shows the scheme of the expected band sizes observed in these gels.
We expected to see as many bands as there were different integration sites occurring
at the nic site (Fig. 3a), depending on the location of the nearest restriction site in the
genomic junction. If integration did not occur at the nic site, the size of the band would
be determined by the nearest recognition site in the integrated plasmid (220 bp when
using BfaI and 580 bp when using Tsp509I, since this does not cut in the oriT but in
trwA; Fig. 3b). In the case of the HeLa::oriT cell line, which has an oriT copy integrated
in the genome, we expected to obtain in all cases a major band of 220 bp (BfaI) or 345
bp (Tsp509I) corresponding to the sequence of the oriT-carrying integrated plasmid
(Fig. 3c).
As can be observed in Fig. 3d, a single band was obtained from all samples, which
was obtained either after plasmid transfection or after translocation of TrwC(::BID)-DNA
molecules through the B. henselae T4SS. The size of the band was in all cases that which
was expected for the full-length oriT gene present in the mobilizable plasmids or in the
genomic oriT copy, as explained above and in Fig. 3a to c. For the G418-resistant pools
obtained either after transfection or infection of HeLa::oriT cells, both 345 bp and 580
bp would be visible when using Tsp509I, as observed in the sample obtained after
infection and DNA transfer mediated by TrwC (Fig. 3d, bottom gel, line 6). A reason for
this not being the case for the other samples could be that the smaller amplicon could
be preferentially ampliﬁed.
These results strongly suggest that the transferred DNA had not become integrated
by the nic site at the oriT. Rather, they presumably reﬂect illegitimate integration
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events. Since low-frequency site-speciﬁc integration events could be masked by this
main band, LAM-PCR products were thus analyzed by high-throughput sequencing, as
explained in Materials and Methods. After the identiﬁcation of linker- and plasmid-
speciﬁc sequences, the ﬂanked sequences were characterized. As expected from the
results in Fig. 3d, most of the 2,000,000 reads obtained were found to be plasmid DNA.
This conﬁrms that most of the DNA entering the human cell covalently linked to TrwC
is not integrated at the nic site, implying that this DNA is recircularized prior to
integration.
There were 11,317 reads which could be mapped to the human genome. To discard
false positives, identity to the human genome threshold was raised to 98%, and
integration events obtained15 times were not considered. The resulting 9 integration
events (IE) are shown in Table 3. IE1 and IE2 were found to occur at the same site of the
FIG 3 Analysis of LAM-PCR products. (a to c) Scheme of the expected integration events and the subsequent LAM-PCR products. (a) If integration
takes place by the 5= end of the nic site, the size of the LAM-PCR would be determined by the distance to the nearest restriction site in the human
genome (in pink). Each integration event occurring in a different locus would generate a band of a different size. The nicked oriT is indicated by
a slash. (b) If the plasmid becomes integrated at any other region than the nic site, the size of the LAM-PCR product would be always the same
and would be determined by the distance to the restriction site in the plasmid sequence. Bfa, BfaI; Tsp, Tsp509I. (c) In HeLa::oriT cell line, in
addition to the bands generated from the integration events, the oriT copy present in the pMTX708/pMTX709 plasmid generates a single band
of a size determined by the distance to the restriction site in the plasmid sequence. trw has been omitted from trwA, trwB, and trwC for clarity.
(d) Gel electrophoresis of LAM-PCR products obtained when using BfaI (top gel) or Tsp509I (bottom gel) restriction enzymes. The cell line is
indicated in the top row (EA, EA.hy926; He, HeLa; He:oriT, HeLa::oriT). Inf, samples obtained after Bartonella infection; Tr, samples obtained by
transfection of plasmid DNA; LD, 100-bp ladder; T, trwC-coding plasmid (pCOR31); T:B, trwC::BID-coding plasmid (pCOR33). EA, He, and He::oriT,
samples from uninfected cell lines. g, human genomic DNA (Roche), used as negative control. The  sign with 1 to 3, negative controls (no DNA)
of linear, ﬁrst, and second exponential PCRs, respectively. The arrows indicate the bands of the expected size according to panels b (black arrows)
and c (blue arrow).
TABLE 3 Integration events characterized by LAM-PCR and DNA sequencinga
IE Cell line Relaxase
No. of
sequences Identity (%) Chr
Integration
locus Missing bp
1 EA.hy926 TrwC 19 99.75 11 35225119 0
2 EA.hy926 TrwC 402 100 11 35225119 0
3 HeLa TrwC::BID 15 98.25 2 37383046 15
4 HeLa TrwC::BID 114 100 2 111118923 16
5 HeLa TrwC::BID 15 100 6 9173423 18
6 HeLa TrwC::BID 84 99.48 12 28128063 16
7 HeLa TrwC::BID 21 100 13 83099211 0
8 HeLa TrwC::BID 95 99.72 16 68832248 16
9 HeLa TrwC::BID 15 100 19 18303607 14
aThe information collected for each integration event is shown. Number of sequences indicates the number
of times the sequence read was found. Missing base pairs indicates the number of bp that are missed in
the read with respect to the plasmid sequence until the nic site. IE, integration event; Chr, chromosome.
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human genome (the differences in the sequencing reads were assumed to be sequenc-
ing errors), so they were considered together as one integration event and named IE2.
Most of the integration events showed more than 12 missing bp of a total of 41 bp
ampliﬁed from primer oriTI binding site to the nic site, so they were considered random
integration events.
There were only two IE which were not missing any oriT sequence in the 3= direction
of the nic site. When aligned with the human DNA sequence, it was found that
integration in IE2 had occurred at the position nic1, since this base from the oriT
sequence was present at the junction and is not present in the University of California,
Santa Cruz (UCSC) genomic sequence used as a reference. We conﬁrmed the genomic
sequence of this position in the genome of the HeLa cells used in the experiment by
ampliﬁcation of the chromosomal region around the integration site 2 (IS2) with
primers IS2_Hu11 and Xba_IS2_Hu11 (Table 2) and sequencing the PCR product with
the IS2_Hu11 primer, and this base pair was not present there either. Considering the
high speciﬁcity of conjugative relaxases for nicking exactly at their nic site, this result
suggests that this event was yet another illegitimate integration event. Finally, IE7
occurred exactly at the nic site, and moreover, the eight nucleotides of the human
genome in the 5= direction of the integration site are identical to the eight nucleotides
in the 5= direction of the nic site in R388 oriT (Fig. 4). This integration event took place
1,352,133 bp downstream of the SLITRK1 gene (accession no. NM_052910) in human
chromosome 13.
As LAM-PCR did not allow the detection of the integration events occurring at the
oriT copy present in the chromosome of HeLa::oriT cells, we tried to detect them by PCR
ampliﬁcation of the expected cointegrate molecule; we used a primer annealing in the
Ptac promoter located adjacent to the chromosomal oriT copy and another one
annealing in the mobilizable plasmid (Table 2). As a control, the chromosomal Ptac-oriT
cassette was ampliﬁed in the same samples analyzed; as expected, the cassette was
detected in HeLa::oriT and the G418-resistant pools obtained with this cell line, while no
ampliﬁcation was obtained in HeLa and HeLa-derived cell pools. The PCR to amplify the
oriT-oriT cointegrate was negative (data not shown), even after a second round of PCR
ampliﬁcation. Although we cannot discard oriT-speciﬁc integration occurring at such
low frequency that it is not detectable by PCR, this result indicates that it is not
occurring efﬁciently.
LAM-PCR can only be used to map those integration events that occurred by a
known sequence of the transferred DNA (the nic site in our case), but most of the
plasmid molecules became integrated in a nic-independent manner. Out of the 8
human genomic junctions obtained by LAM-PCR (Table 3), 7 did not occur by the nic
site, and so they represent random integration events. However, they provide infor-
mation on only one of the integration junctions of the plasmid. We attempted to
characterize other random integration sites by recovery of the integrated plasmids
together with the ﬂanking genomic sequences, as outlined in Materials and Methods.
With this strategy, we were able to characterize one integration event and its corre-
sponding plasmid-genomic DNA junctions (Fig. 5). We determined that only a fragment
of the plasmid was integrated, which does not include the neomycin resistance gene,
so most probably, there is another integration event somewhere else in that same cell
FIG 4 Characterization of integration event IE7. The genome-plasmid integration junction (IJ) is aligned
with the DNA sequence around the nic site (oriT, top) and the chromosomal integration site (IS, bottom).
DNA of plasmid origin is shown in blue, and genomic DNA is shown in black. The nic site and insertion
sites are indicated by a slash. Regions of homology between the plasmid and the genomic sequences are
boxed.
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containing the neo gene. We also observed that both genomic-plasmid DNA junctions
did not occur at the same position in the human genome. Moreover, near one of the
junctions (IJ-B in Fig. 5b), a genomic rearrangement was found, compared to the
reference genome (see coordinates in Fig. 5b). The reason could be that the genomic
region of chromosome 15 where integration occurred corresponds to a copy of L1MC2,
a long interspersed element (LINE) often associated with genomic rearrangements and
deletions (26). We tried to sequence that region from genomic DNA of the HeLa cell line
used in the experiment using primer Chr15_88728 (Table 2) to determine if the
rearrangement was already present or it was a consequence of the illegitimate inte-
gration event, but mixed sequences were always obtained.
The genomic integration sites of all random integration events characterized were
aligned with the R388 nic region at the oriT gene (Table 4). No homology with the oriT
was detected, supporting the idea of illegitimate integration.
FIG 5 Genomic integration event characterized by recovery of the integrated plasmid. (a) Scheme of the
mobilizable plasmid containing trwC::BID, and the structure of the integrant in the genomic DNA of HeLa
cells. Plasmid DNA is represented as a blue horizontal line and HeLa genomic DNA as a black dashed line.
trw is omitted from trwA, trwB, and trwC::BID for clarity. The double slash in the integrant refers to the
genomic reorganization shown in panel b. The two plasmid-genomic DNA integration junctions resulting
from the integration event are named IJ-A and IJ-B. The DNA sequence at the junctions is shown below
with their respective coordinates, in black (human genome) and blue (plasmid DNA). The junctions are
highlighted in a square. Coordinates of human chromosome 15 are indicated as a C-number, where the
number corresponds to the coordinates of the human genome in UCSC database (assembly GRCh37/
hg19). Coordinates of plasmid DNA are indicated as a P-number, where the number corresponds to the
nucleotide of the open reading frame of gfp (in IJ-A) or trwA (in IJ-B). (b) Genomic rearrangement found
near IJ-A. The red slash indicates the genomic junction between nonadjacent human DNA sequences.
TABLE 4Mapped illegitimate integration eventsa
IS Sequence (5= to 3=)
Integration junction
Chr Genomic locus Plasmid
2 AAAATGAGGACAGTT/ATATTTTTTAAATGT 11 35225119 nic1
3 CCAGATCGTGCCACT/GCATTCCAGCCTGGC 2 37383046 nic15
4 TGGGAAACAAATGAA/GAAACAACCCTGCTG 2 111118923 nic16
5 GTTTCCATGGACATT/TGCCACCCCGGCTTC 6 9173423 nic18
6 CGGGTTAGAAACCAA/GCACCCAAGCCGGCG 12 28128063 nic16
8 CACTTGCTGGGCTCA/GAGACAACCCAGCCC 16 68832248 nic16
9 GTTGTAACTGCCTAA/GATTGACCAACCCTA 19 18303607 nic14
10 GTCACATGATAAAAA/GATTATTTCATTTTG 15 60623276 gfp_73
11 ATTTAATCCAAATAG/AAATAAGTTTCAGAT 15 60724330 trwA_353
oriT AGGTGCGTATTGTCT/ATAGCCCAGATTTAA nic
aThe genomic integration sites are shown aligned with the wild-type target for TrwC, the oriT gene. The
slash in each sequence indicates the integration site (the nic site in the oriT sequence). The location of the
integration site (Chr, chromosome number), as well as the nucleotide of the plasmid by which integration
took place, is also displayed. IS, integration site. IS2 to -9 were characterized by LAM-PCR. IS10 and -11 are
both integration junctions of the event characterized by recovery of the integrated plasmid. Coordinates of
genomic loci correspond to human genome GRCh37/hg19 available in UCSC Genome Browser. Plasmid
coordinates refer to the distance from the nic site ( and  indicating in the 5=or 3= direction from the nic
site, respectively) for IS2 to -9, or the nucleotide position in the gfp and trwA open reading frames (ORFs)
for IS10 and -11.
González-Prieto et al. Applied and Environmental Microbiology
June 2017 Volume 83 Issue 12 e00207-17 aem.asm.org 10
DISCUSSION
The ability to deliver DNA into speciﬁc human cell types and to promote its
integration in the human genome has high potential as a biotechnological tool. In
particular, gene therapy strategies ideally should grant in vivo access to speciﬁc human
tissues and permanent expression of the introduced DNA. In this work, we explore the
potential of a bacterial system for genomic modiﬁcation of the human genome. Our
previous work showed that the substrate of a conjugative plasmid, the TrwC-DNA
complex, was delivered efﬁciently to human cells through the T4SS of B. henselae (17);
the many advantages of such a DNA delivery system in this context have been already
discussed (19). We previously showed in a bacterial system that TrwC could catalyze
integration of the transferred DNA into DNA sequences of human origin (12), so we
aimed to evaluate its potential role as a site-speciﬁc integrase in human cells, which
would complement the DNA delivery tool. We have analyzed the fate of the DNA in
human cells after translocation as a TrwC-DNA complex through the VirB/D4 T4SS of B.
henselae.
We measured the efﬁciency of DNA delivery and integration by the two relaxases
previously described to deliver DNA through the T4SS VirB/D4 of B. henselae, TrwC and
Mob::BID. All mobilizable plasmids carried a eukaryotic expression GFP cassette, allow-
ing us to estimate the efﬁciency of DNA transfer by measuring the percentage of
GFP-positive cells. This assay probably underestimates the percentage of cells receiving
DNA, since this DNA has to get into the nucleus and be converted into double-stranded
form so that it can express the gfp gene. Thus, nuclear localization of the relaxase could
affect DNA transfer rates. TrwC has been reported to have cytoplasmic localization (27),
while a passive entry of the Mob-guided DNA has been suggested (16), so none of the
relaxases is expected to have an active role in nuclear import.
Our results show that DNA transfer is higher when using TrwC than when using
Mob::BID. The differences in DNA transfer rates are probably due to differences in T4SS
recruitment efﬁciency for each relaxase. TrwC could be naturally a better substrate for
the B. henselae VirB/D4 T4SS than Mob::BID. There is another important factor to take
into account: the mobilizable plasmids carrying trwC also code for R388 proteins TrwA
and TrwB, which could play a role in substrate recruitment. Deletion of trwB was shown
to affect signiﬁcantly the transfer of TrwC-DNA complexes (17). Thus, it is likely that
TrwB enhances recruitment of TrwC by the VirB/D4 T4SS independently of BID, as
previously suggested (16, 18).
The plasmids mobilized to human cells carried a eukaryotic resistance marker to
select for stable integration events by antibiotic treatment. Selection was carried out for
4 weeks, discarding the possibility of episomal persistence of the transferred plasmid
DNA. Each resistant colony was counted as one integration event. Again, this measure
is an underestimation of the integration rate. A single colony could harbor more than
one integration event; in fact, the only integration event mapped in its entirety (the
rescued integrated plasmid) did not include the neo region (Fig. 5a), implying this gene
must be integrated somewhere else in the genome. In addition, not all cells integrating
the plasmid will thrive to render a colony. This phenomenon was particularly evident
with EA.hy926 cells, which have low viability. Consequently, we obtained fewer resis-
tant colonies when using EA.hy926 than when using sturdy HeLa cells, despite the fact
that DNA transfer was up to 10-fold higher with EA.hy926 (Fig. 2). Of course, we cannot
rule out that the different integration rates observed in the two cell lines are due to
intrinsic differences affecting host-mediated integration of foreign DNA.
The number of integration events obtained for each experiment was 25 to 158 times
higher when either TrwC or TrwC::BID was present than with Mob::BID (Table S2). When
we measured integration rates, calculated as the number of resistant colonies normal-
ized to the number of cells expressing the transferred DNA, we observed that the
integration rate for TrwC was, on average, 1 in 20, while for Mob::BID, it went down to
about 1 in 250, similar to the integration rate obtained for transfected cells (Fig. 2d and
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Table S2). Thus, we conclude that TrwC facilitates the integration of the mobilizable
plasmids, while Mob does not.
A plausible explanation for this difference could be the site-speciﬁc integration
activity of TrwC, which is presumably absent in the Mob relaxase. To test this hypoth-
esis, we analyzed the integration pattern in the human genome, searching for TrwC-
mediated site-speciﬁc integration events. Their signature would be the precise inte-
gration of the R388 nic site into human DNA sequences resembling the natural TrwC
target. We analyzed genomic DNA of the resistant cell pools by LAM-PCR, priming from
the plasmid DNA into the nic site, and subsequent DNA sequencing. The results showed
the presence of intact oriT sequences in the vast majority of the sequencing reads. One
possible explanation is the integration of plasmid concatemers, as it happens in the
integration of transfer DNA (T-DNA) mediated by A. tumefaciens (28), but then oriT-host
genome junctions would be detected at the end of the concatemer. The DNA extrac-
tion kit isolates high-molecular-weight DNA (30 to 50 kb) from mammalian cells, while
bacterial cells are not lysed, discarding the possibility that plasmid DNA of bacterial
origin could be coisolated. In addition, the absence of transformants when using the
same DNA preparations for plasmid rescue (a single transformant was obtained,
originated from a rescued integrated plasmid copy) rules out the presence of episomal
plasmid molecules. Thus, the most likely possibility is that these reads represent
random integration events of the plasmid, which would have been recircularized
previously, since it enters the human cell cut at the nic site (where TrwC is covalently
bound). Recircularization implies that TrwC is active in the human recipient cell,
mimicking its activity in the bacterial recipient cell during conjugation (29).
Out of the thousands of different integration events present in the analyzed cell
pools, we detected one putative site-speciﬁc integration event (IE7). It occurred pre-
cisely at the nic site and in a region of the genome showing 8 bp identity with the oriT
at the 5= end of the nic site (Fig. 4). Since the probability of integration at any position
of the human genome is approximately 1/(3  109), and the probability of integration
occurring by the nic site is less than 1/(1  104) (the size of the integrated plasmids is
around 13 kb), the probability of this event occurring randomly is negligible. From our
results, we infer that TrwC can act as a site-speciﬁc integrase in human cells, but
host-mediated random integration is at least 3 to 4 logs more efﬁcient. Thus, after
TrwC-mediated recircularization of the DNA (as inferred from the presence of full-
length oriT genes), most molecules would undergo nonhomologous integration events,
as observed in the characterized integration sites (Table 4).
DNA can also be delivered into human cells by the relaxases Mob and A. tumefaciens
VirD2, and it integrates randomly in the genome (16, 30). It was proposed that these
relaxases do not play a role in the integration process, which is likely mediated by the
host machinery, but they do protect the 5= end of the transferred DNA, based on
preservation of the 5=-end region of the transferred DNA molecules (16, 30). In our case,
we found by LAM-PCR seven integration events occurring within 20 bp from the nic site
(Table 3). By chance, we would expect around 30 integration events lying in a
20-nucleotide (nt) region, from about 20,000 total integration events analyzed, so TrwC
does not seem to protect the 5= end of the transferred DNA but rather catalyzes its
conversion to a circular form. Recircularized plasmid DNA will be a more resistant
molecular species, showing long-term presence in the nucleus, which could favor its
subsequent random integration by the host machinery.
From a biotechnological point of view, our results indicate that TrwC is not useful as
a site-speciﬁc integrase in human cells. However, with the introduction of precision
genome editing using RNA-guided endonucleases, such as Cas9 (31), we have entered
a new era of genetic engineering and gene therapy which is making obsolete the
traditional site-speciﬁc recombinases and nucleases used for gene targeting in human
cells (32). In this new scenario, an improvement in clustered regularly interspaced short
palindromic repeat (CRISPR)-associated protein (Cas) technology would have an imme-
diate impact in the human gene editing ﬁeld. An RNA-guided nuclease could be
translocated simultaneously with TrwC-DNA through the T4SS of bacteria that infect
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speciﬁc human cell types. Delivery of the nuclease protein instead of transfection of the
gene could avoid toxicity and off-target activity. The effect of TrwC as a DNA chaperone
in combination with a site-speciﬁc nuclease would promote integration of the incom-
ing DNA molecule by homologous recombination. In support of this approach, it has
been reported that concomitant translocation of I-SceI homing site-speciﬁc endonu-
clease together with VirD2 relaxase-T-DNA complexes through the A. tumefaciens T4SS
enhanced T-DNA site-speciﬁc integration into the yeast chromosome when the I-SceI
target site was present (33).
MATERIALS AND METHODS
Bacterial strains and growth conditions. Escherichia coli strain D1210 (34) was used for DNA
manipulations, while strain 2163 (35) was used as a donor for conjugative matings to B. henselae. E. coli
strains were grown at 37°C in Luria-Bertani broth, supplemented with agar for growth on plates. B.
henselae strain RSE247 (36) was used for the infection of human cells. B. henselae was grown on Columbia
blood agar (CBA) plates at 37°C under a 5% CO2 atmosphere. For selection, antibiotics were added at the
indicated concentrations: ampicillin (Ap), 100 g/ml; kanamycin monosulfate (Km), 50 g/ml; strepto-
mycin (Sm), 300 g/ml (E. coli) or 100 g/ml (B. henselae); and gentamicin sulfate (Gm), 10 g/ml. When
needed, media were supplemented with diaminopimelic acid (DAP) at 0.3 mM.
Plasmids. Bacterial plasmids are listed in Table 1. Plasmids were constructed using standard
methodological techniques (37). Primers used in plasmid constructions are listed in Table 2. Plasmids
pCOR31, pCOR33, and pCOR35 were constructed by cloning a neomycin resistance cassette ampliﬁed
from pRS56 with primers adding ClaI restriction sites (Table 2) into the same site of pHP159, pLA24, and
pHP181, respectively. Plasmids pMTX708 and pMTX709 were constructed by cloning a Ptac-oriT cassette
into the NotI site of pTRE2hyg vector, selecting both orientations; Ptac-oriT was ampliﬁed from plasmid
pOD1, which carries an EcoRI-HindIII fragment from pSU1186 (38) containing R388 oriT into the same
sites of expression vector pKK223-3 (Pharmacia). Restriction enzymes, shrimp alkaline phosphatase, and
T4 DNA ligase were purchased from Thermo Fisher Scientiﬁc. Kapa HiFi DNA polymerase was purchased
from Kapa Biosystems. Plasmid DNA was extracted using the GenElute plasmid miniprep kit (Sigma-
Aldrich). The DNA sequences of all cloned PCR fragments were determined.
Mating assays. Plasmids were routinely introduced in B. henselae by conjugation. The E. coli donor
strain was grown in LB to stationary phase. Two hundred microliters was collected for each mating and
resuspended in 1 ml of phosphate-buffered saline (PBS). Recipient B. henselae was grown in CBA plates
for 3 to 4 days. After that time, bacteria from half of the plate were collected with a cotton swab and
resuspended in 1 ml of PBS. Both donor and recipient aliquots were centrifuged, pellets were resus-
pended in 20 l of PBS and mixed, and the mixture was placed on a cellulose acetate ﬁlter on a CBA plate
supplemented with DAP. The mating plate was incubated at 37°C under a 5% CO2 atmosphere for 6 h.
Transconjugants were selected by recovering the mating mixture and streaking it on a CBA plate with
appropriate antibiotics. The plate was incubated for 6 to 9 days at 37°C under a 5% CO2 atmosphere.
Cell lines and growth conditions. The human cell lines used in this work were immortalized
hybridoma EA.hy926 (ATCC CRL-2922), a fusion cell line of human umbilical vein endothelial cells
(HUVEC) and adenocarcinomic human alveolar basal epithelial cells (A549), and HeLa (ATCC CCL-2),
epithelial cells of cervix adenocarcinoma. HeLa cells containing an integrated copy of the R388 oriT gene
were created by transfection of plasmids pMTX708 and pMTX709 (Table 1) and selection of stable
transfectants as explained in “Transfections,” below.
Cell lines were routinely grown in Dulbecco’s modiﬁed Eagle medium (DMEM; Lonza) supplemented
with 10% fetal bovine serum (FBS; Lonza) at 37°C under 5% CO2. When indicated, antibiotics were added
to the medium at the following concentrations: G418 disulfate salt (Sigma-Aldrich), 500 g/ml; hygro-
mycin B (Invitrogen), 80 g/ml; and penicillin-streptomycin 1% (Lonza).
Transfections. HeLa cells were transfected with the cationic JetPei transfection reagent (Polyplus-
transfection). The amounts of DNA and JetPei reagent were adjusted depending on the cell culture
format used, according to the manufacturer’s instructions. DNA was quantiﬁed using a NanoDrop
ND-1000 spectrophotometer (Thermo Scientiﬁc). To generate stably transfected cell lines, HeLa cells were
allowed to grow and to express the drug resistance gene under nonselective conditions for 24 to 48 h
after transfection. Then, cells were cultivated in standard medium supplemented with the appropriate
drug for 4 to 5 weeks until outgrowth of resistant cells. Medium was changed every 2 to 3 days to avoid
a loss of selection pressure. To obtain the integration rate of transfected plasmid DNA, transfections were
carried out in 6-well plates. To transfect linearized DNA, plasmid DNA was digested with Alw44I (Thermo
Scientiﬁc) and puriﬁed with the GeneJet gel extraction kit (Thermo Scientiﬁc) prior to transfection.
Cell infections. B. henselae containing the appropriate plasmids was grown on CBA plates for 3 to
4 days. Human cells were seeded the day before the infection. For routine infections, cells were seeded
in 6-well plates (80,000 cells per well) in 3 ml of medium. When the purpose of the infection was to select
human cells that had stably acquired the plasmid transferred from B. henselae, infections were performed
in 150-mm tissue culture dishes seeded with 1.2  106 cells in 20 ml of medium.
The day of infection, DMEM was replaced by M199 medium (Gibco) supplemented with 10% FBS and
appropriate antibiotics to select for the B. henselae strains to be added. The bacteria were recovered from
the CBA plate and resuspended in 1 ml of PBS. The number of bacteria was calculated considering that
an optical density at 600 nm (OD600) of 1 corresponds to 109 bacteria/ml (39). Bacteria were added to the
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human cells to get a multiplicity of infection (MOI) of 400. The mixture of human cells and bacteria was
incubated for 72 h at 37°C under 5% CO2.
Detection of GFP-positive cells. At 72 h postinfection (hpi), infected cells were washed with PBS,
trypsinized, and analyzed by ﬂow cytometry using a Cytomics FC500 ﬂow cytometer (Beckman Coulter).
Uninfected cells were always used in parallel to set the baseline for the detection of GFP-positive cells.
Selection of stable integration events. At 72 hpi, G418 disulfate salt (Sigma-Aldrich) was added to
infected cells, and selection was maintained for 4 to 5 weeks. Resistant colonies were counted on the
plates. G418-resistant cell pools were collected for further analysis of GFP expression and PCR analysis.
Genomic high-molecular-weight DNA was extracted using the High Pure PCR template preparation kit
(Roche).
Linear ampliﬁcation-mediated PCR. Ampliﬁcation of genomic integration sites by linear
ampliﬁcation-mediated PCR (LAM-PCR) was performed as described in reference 40. Brieﬂy, it consists of
an initial linear ampliﬁcation of genome-plasmid junctions with a plasmid-speciﬁc primer. After synthesis
of double-stranded DNA (dsDNA), the PCR product is cut with a restriction enzyme (BfaI or Tsp509I), and
a linker cassette of known sequence is ligated. Exponential PCR ampliﬁcations are then performed with
plasmid- and linker-speciﬁc primers. PCR-obtained bands are then analyzed by gel electrophoresis and
high-throughput sequencing. Human genomic DNA from human blood (buffy coat; Roche) was analyzed
in parallel as a negative control.
The LAM-PCR template was genomic DNA from the G418-resistant pools. PCRs were carried out using
Taq DNA polymerase (Genaxxon Bioscience). High-performance liquid chromatography (HPLC)-puriﬁed
primers (Table 2) were designed using the Primer3Plus software and ordered from Euroﬁns Genomics.
Details on the primers can be found in supplemental Materials and Methods and Fig. S1.
High-throughput sequencing of LAM-PCR products. The DNA sequence of puriﬁed LAM-PCR
products was determined using MiSeq benchtop next-generation sequencing technology (Illumina). The
appropriate volumes of different puriﬁed samples were mixed together, according to the manufacturer’s
recommendations. The primers used in the second exponential ampliﬁcation contained the adaptor
sequences needed for the sequencing reaction (PE-PCR 1.0 and 2.0; see Table 2). LAM-PCR products were
sequenced in both directions. From PE-PCR 1.0 (adaptor present in the primer annealing to the
plasmid sequence), 400 nt were sequenced, while only 50 nt were sequenced from PE-PCR 2.0 (adaptor
present in the primer annealing to the linker). Information from PE-PCR 1.0 was used for sorting the
sequences to the different samples and integration site detection, while information obtained from
PE-PCR 2.0 was used for sorting only.
Bioinformatic analysis to obtain the integration sites was performed by high-throughput insertion
site analysis pipeline (HISAP) (41). Brieﬂy, sequences were trimmed by identiﬁcation and removal of
plasmid- and linker-speciﬁc sequences. Genomic sequences were aligned to the human genome using
standalone BLAT (UCSC), using assembly GRCh37/hg19 as a reference. Sequences with identities lower
than 95% were discarded. For each remaining sequence, the chromosome, the integration site, and the
nearest RefSeq protein-coding gene were recorded.
Detection of oriT-speciﬁc integration events by PCR. PCRs were carried out using Kapa Taq
polymerase (Kapa Biosystems), according to the manufacturer’s recommendations. Twenty-ﬁve nano-
grams of plasmid DNA or 250 ng of genomic samples was used as the template. To detect the expected
cointegrate molecule, primers NotI_Ptac and Int_pCOR (Table 2) were used for initial ampliﬁcation. A 1:50
dilution of the initial PCR products served as the template for the secondary PCR, carried out with primers
NotI_Ptac_2 and Int_pCOR_2 (Table 2), annealing approximately 80 bp closer to the expected integration
junction. Primers NotI_Ptac and NotI_oriT1 (Table 2) were used to amplify the chromosomal Ptac-oriT
cassette.
Recovery of integrated plasmids. Five micrograms of genomic DNA from G418-resistant cell pools
was digested with XmaJI (Thermo Fisher Scientiﬁc), which does not cleave within the integrated plasmid.
Digested DNA was treated with T4 DNA ligase at a DNA concentration of 10 g/ml to favor self-ligation.
The reaction mixture was electroporated into ElectroMAX DH10B E. coli cells (Thermo Fisher Scientiﬁc).
Plasmid DNA was extracted from gentamicin-resistant E. coli transformants and analyzed by PCR to
narrow down the region of the plasmid where the insert of human origin was located. The primers used
for PCR mapping reactions are shown in Table 2. The insert in plasmid pCOR52 was sequenced with
primers pCOR33_1641F and pCOR33_12445R (Table 2).
Statistical analysis. An unpaired Student’s t test was used to determine statistically signiﬁcant
differences between the means of at least 3 independent results for each experiment when the data
showed a normal distribution. Otherwise, a Wilcoxon rank sum analysis was performed for each pair of
compared data.
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